US/Silver Spring:
Camber Pharmaceuticals, Inc., a Piscataway, New Jersey, establishment, recalls all all unexpired batch/lots of Valsartan Tablets due to suspected N-Nitrosodimethylamine (“NDMA”) contamination and consequential risks of Carcinogen damage and Cancer, all serious health hazards.
Direct link: https://www.fda.gov/Safety/Recalls/ucm616405.htm
Additional information:
The US Food and Drug Administration (“FDA”) reports the following Valsartan Tablets are subject to this recall:
Filed under: Drugs, Medical / Veterinary, N-Nitrosodimethylamine, US FDA, Valsartan | Tagged: Camber Pharmaceuticals, Carcinogenic contamination, FDA, N-Nitrosodimethylamine contamination, Qualanex, Recalls Direct RIN: 10506-2018, US Food and Drug Administration, Valsartan, Valsartan Tablets USP | Leave a comment »